Showing results (261-270 of 277) with videos related to

Sort By:
Pageof 28
Bioactive Materials|November 30, 2023
Hypoxia endothelial cells-derived exosomes facilitate diabetic wound healing through improving endothelial cell function and promoting M2 macrophages polarizationPeng Cheng, Xudong Xie, Liangcong Hu, et al.
Clinical Transplantation|February 10, 2026
Association of CYP2C19 Single Nucleotide Polymorphism With Hemorrhagic Cystitis After Pediatric Allogeneic Hematopoietic Stem Cell TransplantationWeiliang Zhang, Qi Ji, Qingwei Wang, et al.
Frontiers in Immunology|August 6, 2025
Impact of cyclosporine A-related single nucleotide polymorphisms on post-transplant outcomes in pediatric hematologic malignancy patients undergoing allogeneic hematopoietic stem cell transplantationQi Ji, Senlin Zhang, Minyuan Liu, et al.
Chemical Reviews|April 1, 2021
Molecular Characterization of Polymer NetworksScott P O Danielsen, Haley K Beech, Shu Wang, et al.
Cancer Cell International|June 18, 2026
BRD4 regulation of PIM1 identifies a novel therapeutic vulnerability in acute megakaryoblastic leukemiaAilian Guo, Fang Fang, Peifang Xiao, et al.
Genome Biology|August 31, 2023
Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AMLYongping Zhang, Shuting Jiang, Fuhong He, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Experimental Hematology & Oncology|March 2, 2025
IRF1 is a core transcriptional regulatory circuitry member promoting AML progression by regulating lipid metabolismFenli Zhang, Zhiheng Li, Fang Fang, et al.
Blood Advances|March 31, 2021
Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational studyYixin Hu, Aili Chen, Li Gao, et al.
Hematology (Amsterdam, Netherlands)|August 18, 2023
BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3Li Ma, Jianwei Wang, Yang Yang, et al.
Pageof 28